Neisseria meningitidis Endotoxin and Capsule Transmission by Transplantation
Nareg Roubinian*, Beth D. Kirkpatrick*, Freyja Lynn†, Jonathan Zenilman‡, and Margaret Bash†
Author affiliations: *University of Vermont College of Medicine, Burlington, Vermont, USA; †US Food and Drug Administration, Rockville, Maryland, USA; ‡Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Figure. . Pre- and posttransplantation serum antibodies as measured by enzyme-linked immunosorbent assay (ELISA). A) Immunoglobulin (Ig) G antibodies to Neisseria meningitidis serogroup C capsular polysaccharide (CPS) determined as described by Arakere and Frasch (7) with minor modifications. Samples were run in duplicate at 8 serial dilutions, and antibody concentrations were calculated relative to the standard reference serum lot CDC 1992 (courtesy of G. Carlone, Centers for Disease Control and Prevention, Atlanta, GA). B) IgM antibodies to N. meningitidis lipooligosaccharide (LOS) immunotypes (L2, L3, L7, L9). ELISA to detect antibodies to LOS immunotypes L2, L3, L7, or L9 was performed as described (8), with minor modifications, by using goat antihuman IgG (γ-specific, Kirkegaard & Perry, Gaithersburg, MD, USA) or goat antihuman IgM (μ-specific, Sigma, St. Louis, MO, USA) conjugated to alkaline phosphatase. Samples were run in duplicate at 4 serial dilutions. OD, optical density.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.